Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.

Karlowsky, James A; Nichol, Kim; Zhanel, George G

Karlowsky, James A; Nichol, Kim; Zhanel, George G.

Affiliation

Karlowsky JA; Department of Medical Microbiology, College of Medicine, University of Manitoba Diagnostic Services Manitoba, Winnipeg, Canada.
Nichol K; Diagnostic Services Manitoba, Winnipeg, Canada.
Zhanel GG; Department of Medical Microbiology, College of Medicine, University of Manitoba.

Clin Infect Dis ; 61 Suppl 2: S58-68, 2015 Sep 15.

Article in En | MEDLINE | ID: mdl-26316559

Subject(s)

Aminoglycosides/pharmacology; Aminoglycosides/therapeutic use; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Drug Resistance, Bacterial; Gram-Positive Bacteria/drug effects; Drug Resistance, Bacterial/genetics; Enterococcus/drug effects; Enterococcus/genetics; Gram-Positive Bacterial Infections/drug therapy; Gram-Positive Bacterial Infections/microbiology; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus/drug effects; Microbial Sensitivity Tests; Staphylococcal Infections/drug therapy; Staphylococcal Infections/microbiology; Staphylococcus/drug effects; Staphylococcus/genetics; Streptococcus/drug effects; Streptococcus/genetics

Key words

drug resistance; mechanism of action; methicillin-resistant Staphylococcus aureus; revised MIC break point; telavancin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Drug Resistance, Bacterial / Gram-Positive Bacteria / Aminoglycosides / Anti-Bacterial Agents Type of study: Guideline Language: En Journal: Clin Infect Dis Year: 2015 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google